WHOOP Raises $575 Million at $10.1 Billion Valuation to Advance Global Health Platform

March 31, 2026

WHOOP, the human performance company, today announced it has raised $575 million in Series G funding at a $10.1 billion valuation, advancing its global expansion and long-term vision for personalized health. The round was led by Collaborative Fund and includes global participation from 2PointZero Group, Qatar Investment Authority (QIA), Mubadala Investment Company, Abbott, Mayo Clinic, Macquarie Capital (entities administered by Macquarie Capital), Glade Brook, B-Flexion, IVP, Foundry, Accomplice, Affinity Partners, Promus Ventures, and Bullhound Capital alongside a group of prominent global athletes and individual investors.

Individual investors in the round include Cristiano Ronaldo, LeBron James, Rory McIlroy, Reggie Miller, Niall Horan, Karen Wazen, Virgil van Dijk, Mathieu van der Poel, and Shane Lowry, underscoring the deep connection between WHOOP and elite performance, health, and global culture.

This funding comes at a defining moment for WHOOP and the future of health. Chronic disease is rising globally, while many healthcare systems remain built for reactive care. At the same time, advances in AI and continuous biometric data are enabling a fundamentally new approach that predicts risk, guides behavior, and improves health in real time. WHOOP has spent over a decade building toward this moment. With this investment, the company will accelerate global expansion and scale its platform as a new standard for personalized, preventive health. Business Wire